Ripasudil 0.4% Eye Drops
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ripasudil 0.4% Eye Drops, covering 2018-07-12 to 2018-07-12. Get the full timeline:
Most recent: Clinical Trial Update: Ripasudil 0.4% Eye Drops in Fuchs Endothelial Corneal Dystrophy [Phase 2]